Zobrazeno 1 - 10
of 88
pro vyhledávání: '"Z Kolak"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Y. Stroynyiy, Z. Kolak
Publikováno v:
Granì, Vol 19, Iss 11(139), Pp 108-116 (2016)
The level of retailing in Tarnow in the years 2011-2014 has been analyzed. The origins and the development of trade in Tarnow have been shown throughout history. The attention has been drawn to such very important fact as the geographical location of
Externí odkaz:
https://doaj.org/article/0273c964dbda4eb9be50d2e1c3fedd1f
Autor:
A I Tekkesin, T Cetin, Kazım Serhan Özcan, Mert İlker Hayıroğlu, K Gurkan, AC Yumurtas, AT Alper, C Turkkan, Göksel Çinier, O Tezen, N Ozbilgin, L Pay, S Eren, Tufan Çınar, Z Kolak
Publikováno v:
Web of Science
Background This investigation aimed to examine and compare the predictive value of MADIT-II, FADES, PACE and SHOCKED scores in predicting 1-year and long-term all-cause mortality in implantable cardioverter-defibrillator (ICD) implanted patients who
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7aae84d6e5eb0c959e2e1da7bcea207b
https://doi.org/10.1007/s40520-021-01960-6
https://doi.org/10.1007/s40520-021-01960-6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
L Pay, K Gurkan, Ahmet Taha Alper, Ceyhan Türkkan, N Ozbilgin, Mert İlker Hayıroğlu, Göksel Çinier, Kazım Serhan Özcan, Ahmet İlker Tekkeşin, O Tezen, AC Yumurtas, S Eren, Z Kolak, T Cetin
Publikováno v:
EP Europace. 23
Funding Acknowledgements Type of funding sources: None. Background The benefit of implantable cardiac defibrillator (ICD) in patients with heart failure and reduced ejection fraction (HFrEF) could be limited in a particular group of patients. Low pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b874700484b858ac72c7270b12d5c13
https://doi.org/10.1093/europace/euab116.420
https://doi.org/10.1093/europace/euab116.420
Autor:
Z Kolak, T Cetin, N Ozbilgin, O Tezen, Ahmet Taha Alper, Ceyhan Türkkan, L Pay, Mert İlker Hayıroğlu, S Eren, K Gurkan, Ahmet İlker Tekkeşin, AC Yumurtas, Kazım Serhan Özcan, Göksel Çinier
Publikováno v:
EP Europace. 23
Funding Acknowledgements Type of funding sources: None. Background Implantable cardiac defibrillators (ICD) are recommended in heart failure with reduced ejection fraction (HFrEF) patients to reduce arrhythmic deaths. The only contraindication for no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f3e7cda077d4b37d6af4bd4966f501e0
https://doi.org/10.1093/europace/euab116.422
https://doi.org/10.1093/europace/euab116.422
Autor:
AC Yumurtas, Ahmet İlker Tekkeşin, N Ozbilgin, T Cetin, Kazım Serhan Özcan, Göksel Çinier, Ceyhan Türkkan, Mert İlker Hayıroğlu, L Pay, K Gurkan, Z Kolak, O Tezen, S Eren, Ahmet Taha Alper
Publikováno v:
EP Europace. 23
Funding Acknowledgements Type of funding sources: None. Background Implantable cardiac defibrillators (ICD’s) are recommended in patients with heart failure with reduced ejection fraction (HFrEF) of nonischemic etiology. Determining patients who ar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fdb2a60d4237bbcbdea29789b14b6f62
https://doi.org/10.1093/europace/euab116.423
https://doi.org/10.1093/europace/euab116.423
Autor:
K Gurkan, Z Kolak, Ahmet İlker Tekkeşin, Ceyhan Türkkan, Mert İlker Hayıroğlu, L Pay, N Ozbilgin, Serhan Özcan, Göksel Çinier, T Cetin, AC Yumurtas, Ahmet Taha Alper, O Tezen, S Eren
Publikováno v:
EP Europace. 23
Funding Acknowledgements Type of funding sources: None. Background Patients with heart failure with reduced ejection fraction (HFrEF) who received implantable cardiac defibrillator (ICD) still remain at high risk due to pump failure and comorbid cond
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0025064da0d2ff6dbf2752eeb4caec0d
https://doi.org/10.1093/europace/euab116.421
https://doi.org/10.1093/europace/euab116.421
Autor:
Ahmet İlker Tekkeşin, Ceyhan Türkkan, K Gurkan, Göksel Çinier, N Ozbilgin, S Eren, T Cetin, AC Yumurtas, L Pay, O Tezen, Ahmet Taha Alper, Serhan Özcan, Z Kolak, Mert İlker Hayıroğlu
Publikováno v:
European Journal of Clinical Investigation. 51
Background Patients with heart failure with reduced ejection fraction (HFrEF) who received implantable cardiac defibrillator (ICD) still remain at high risk due to pump failure and prevalent comorbid conditions. The primary aim of this research was t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8b43f891c15f6f2bfce7fd2024ef42d
https://doi.org/10.1111/eci.13550
https://doi.org/10.1111/eci.13550